
Selank Nasal Spray
Pre-formulated calm-focus peptide in metered nasal solution.

Pre-formulated Semax, metered, ready on arrival. See the Semax powder page for full detail.
For research and educational use only. Not for human or veterinary consumption.
SMX-N is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the 4–10 fragment of adrenocorticotropic hormone, with a Pro-Gly-Pro C-terminal extension added for metabolic stability. Critically, the fragment retains none of ACTH's hormonal activity — it does not stimulate cortisol production.
Why intranasal. As with all peptides in this class, oral bioavailability is negligible. Intranasal administration leverages the olfactory and trigeminal pathways and is the route used across essentially the entire published research base for this compound.
What the research literature reports. The most replicated preclinical finding is upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). Dolotov and colleagues (Brain Research, 2006; PMID 16996037) reported that a single intranasal administration in rats produced a 1.4-fold increase in hippocampal BDNF protein and a 1.6-fold increase in TrkB tyrosine phosphorylation, with a 3-fold increase in exon III BDNF mRNA. Research has also examined partial engagement of melanocortin MC3 and MC4 receptors, and effects on attention and working memory. The parent peptide has a very short plasma half-life; downstream signalling effects reported in the literature outlast plasma presence considerably.
The compound is used clinically in Russia as a nasal spray for post-stroke cognitive recovery and optic nerve indications. It is not approved by the FDA or EMA, and is supplied here as a research compound. As with Selank, the strongest data originates in Russian-language literature with limited independent replication.
This formulation. 10 mg of SMX-N in 9 mL of sterile saline (1.11 mg/mL), in a metered pump bottle delivering 0.125 mL per actuation — about 140 mcg per actuation, approximately 72 actuations per bottle. Supplied ready to use.
| SMX-N | ≈139 mcg per actuation |
|---|
| Presentation | Clear glass bottle, white metered pump actuator, screw collar |
|---|---|
| Fill volume | 9 mL sterile 0.9% sodium chloride — plain saline, preservative-free |
| Metered delivery | 0.125 mL per actuation |
| Actuations per bottle | ≈72 (9 mL ÷ 0.125 mL), minus 3–5 for initial priming |
| Concentration | 1.11 mg/mL per compound (≈139 mcg per actuation) |
| Storage | 2–8 °C refrigerated at all times. Do not freeze. Protect from light. |
| After first opening | Single user only. Discard 28 days after first actuation. |
| Batch / expiry | Printed on label (e.g. Batch AV240611, Exp 06/2027) |
Same trade-off as Selank: ready to use arrives pre-mixed with its clock already running; the powder is cheaper and fresher if you're buying ahead.
1 spray, once daily, before 2 PM. Refrigerate. Keep out of light — Semax oxidises. 🛑 Psychiatric gate applies.
1 × 9 mL metered nasal spray bottle with dust cap.
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.

Pre-formulated calm-focus peptide in metered nasal solution.

Both nootropic peptides in a single metered nasal solution.